Immunoassays in R&D Market Research Report - Global Forecast till 2030

Immunoassays in R&D Market Research Report Information by Product & Service (Kits and Reagents Analyzers and Software and Services), Type (Enzyme-Linked Immunosorbent Assay (ELISA), Enzyme-Linked Immunospot Assay (ELISpot), RadioImmunoassay (RIA), chemiluminescence (CLIA), Fluoroimmunoassay and others), Application (Infectious Diseases, Cancer Research, Endocrinology, Autoimmune Diseases and others), End User (Pharmaceutical and Biotechnology Companies, Academic Institutions and Laboratories and Others) and Region (Americas, Europe, Asia-Pa

ID: MRFR/HC/6420-CR | 114 Pages | Author: Kinjoll Dey | August 2019         

1 Report Prologue

2 Market Introduction

2.1 Definition 20

2.2 Scope Of The Study 20

2.3 List Of Assumptions 20

2.4 Market Structure 21

3 Research Methodology

3.1 Research Process 23

3.2 Primary Research 24

3.3 Secondary Research 25

3.4 Market Size Estimation 26

3.5 Forecast Model 26

4 Market Dynamics

4.1 Overview 28

4.2 Drivers 29

4.2.1 Increasing Incidence Rate Of Chronic And Infectious Diseases 29

4.2.2 Increased R&D Investments By Public And Private Organizations 29

4.2.3 Technological Advancements In Immunoassay Testing 30

4.3 Restraints 30

4.3.1 High Cost Of Immunoassay Procedures 30

4.3.2 High Price Of Immunoassay Systems 30

4.4 Opportunity 31

4.4.1 Integration Of The Microfluidics Technology In Immunoassays 31

4.5 Challenge 31

4.5.1 Technical Difficulties During Testing 31

5 Market Factor Analysis

5.1 Value Chain Analysis 33

5.1.1 R&D And Product Development 33

5.1.2 Manufacturing 33

5.1.3 Distribution & Sales 33

5.1.4 Post-Sales Monitoring 34

5.2 Porter’s Five Forces Analysis 34

5.2.1 Bargaining Power Of Suppliers 34

5.2.2 Bargaining Power Of Buyers 35

5.2.3 Threat Of New Entrants 35

5.2.4 Threat Of Substitutes 35

5.2.5 Intensity Of Rivalry 35

5.3 Investment Opportunity Analysis 35

5.4 Pricing Analysis 35

5.5 Major Trends 36

5.5.1 Growing Demand For Automated Immunoassay Systems 36

5.5.2 Development Of Highly Sensitive Immunoassay Equipment 36

5.5.3 Technology Trends 36

5.6 Major Pharmaceutical Organizations (By R&D Revenues) 37

5.7 Top Research Institutes 42

6 Immunoassays In R&D Market, By Product & Service

6.1 Overview 47

6.2 Kits And Reagents 48

6.3 Analyzers 49

6.4 Software And Services 50

7 Immunoassays In R&D Market, By Type

7.1 Overview 52

7.2 Enzyme-Linked Immunosorbent Assay (ELISA) 53

7.3 Enzyme-Linked Immunospot Assay (ELISpot) 54

7.4 RadioImmunoassay (RIA) 55

7.5 Chemiluminescence (CLIA) 56

7.6 Fluoroimmunoassay 57

7.7 Others 57

8 Immunoassays In R&D Market, By Application

8.1 Overview 59

8.2 Infectious Diseases 60

8.3 Cancer Research 61

8.4 Endocrinology 62

8.5 Autoimmune Diseases 63

8.6 Others 63

9 Immunoassays In R&D Market, By End User

9.1 Overview 65

9.2 Pharmaceutical And Biotechnology Companies 66

9.3 Academic Institutions And Laboratories 67

9.4 Others 68

10 Global Immunoassays In R&D Market, By Region

10.1 Overview 70

10.2 Americas 71

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.2.1 North America 74

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.2.1.1 US 77

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.2.1.2 Canada 80

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.2.2 Latin America 82

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3 Europe 85

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.1 Western Europe 88

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.1.1 Germany 92

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.1.2 France 94

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.1.3 UK 97

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.1.4 Italy 99

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.1.5 Spain 102

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.1.6 Switzerland 104

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.1.7 Rest Of Western Europe 107

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.2 Nordic Countries 109

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.2.1 Norway 113

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.2.2 Sweden 115

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.2.3 Denmark 118

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.2.4 Rest Of Nordic Countries 120

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.3.3 Eastern Europe 123

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.4 Asia-Pacific 126

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.4.1 Japan 129

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.4.2 China 132

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.4.3 India 134

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.4.4 Australia 137

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.4.5 South Korea 139

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.4.6 Rest Of Asia-Pacific 142

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.5 Middle East & Africa 145

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.5.1 Middle East 148

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

10.5.2 Africa 151

Immunoassays In R&D Market, By Product & Service

Immunoassays In R&D Market, By Type

Immunoassays In R&D Market, By Application

Immunoassays In R&D Market, By End User

11 Company Landscape

11.1 Overview 155

11.2 Company Share Analysis 155

12 Company Profiles

12.1 Bio-Rad Laboratories, Inc. 158

12.1.1 Company Overview 158

12.1.2 Financial Overview 158

12.1.3 Products/Services Offered 159

12.1.4 Key Developments 160

12.1.5 SWOT Analysis 160

12.1.6 Key Strategies 160

12.2 Thermo Fisher Scientific Inc. 161

12.2.1 Company Overview 161

12.2.2 Financial Overview 161

12.2.3 Products/Services Offered 162

12.2.4 Key Developments 163

12.2.5 SWOT Analysis 163

12.2.6 Key Strategies 163

12.3 Siemens Healthineers 164

12.3.1 Company Overview 164

12.3.2 Financial Overview 164

12.3.3 Products/Services Offered 165

12.3.4 Key Developments 165

12.3.5 SWOT Analysis 165

12.3.6 Key Strategies 166

12.4 Becton, Dickinson And Company 167

12.4.1 Company Overview 167

12.4.2 Financial Overview 167

12.4.3 Products/Services Offered 168

12.4.4 Key Developments 168

12.4.5 SWOT Analysis 169

12.4.6 Key Strategies 169

12.5 Danaher Corporation 170

12.5.1 Company Overview 170

12.5.2 Financial Overview 170

12.5.3 Products/Services Offered 171

12.5.4 Key Developments 171

12.5.5 SWOT Analysis 171

12.5.6 Key Strategies 171

12.6 BioMérieux Inc. 172

12.6.1 Company Overview 172

12.6.2 Financial Overview 172

12.6.3 Products/Services Offered 173

12.6.4 Key Developments 173

12.6.5 SWOT Analysis 174

12.6.6 Key Strategies 174

12.7 Abbott Laboratories 175

12.7.1 Company Overview 175

12.7.2 Financial Overview 175

12.7.3 Products/Services Offered 176

12.7.4 Key Developments 176

12.7.5 SWOT Analysis 176

12.7.6 Key Strategies 176

12.8 F. Hoffmann-La Roche Ltd 177

12.8.1 Company Overview 177

12.8.2 Financial Overview 177

12.8.3 Products/Services Offered 178

12.8.4 Key Developments 179

12.8.5 SWOT Analysis 179

12.8.6 Key Strategies 179

12.9 Sysmex Corporation 180

12.9.1 Company Overview 180

12.9.2 Financial Overview 180

12.9.3 Products/Services Offered 181

12.9.4 Key Developments 181

12.9.5 SWOT Analysis 181

12.9.6 Key Strategies 181

12.10 Abcam Plc 182

12.10.1 Company Overview 182

12.10.2 Financial Overview 182

12.10.3 Products/Services Offered 183

12.10.4 Key Developments 183

12.10.5 SWOT Analysis 183

12.10.6 Key Strategies 184

13 Appendix

13.1 Discussion Blue Print 186

14 List Of Tables

TABLE 1 MARKET SYNOPSIS 18

TABLE 2 LIST OF ASSUMPTIONS 20

TABLE 3 TOP COMPANIES (GLOBAL) 37

TABLE 4 TOP AMERICAS COMPANIES 38

TABLE 5 TOP EUROPE COMPANIES 39

TABLE 6 TOP ASIA-PACIFIC COMPANIES 40

TABLE 7 TOP MIDDLE EAST & AFRICA COMPANIES 41

TABLE 8 TOP RESEARCH INSTITUTES IN THE AMERICAS 42

TABLE 9 TOP RESEARCH INSTITUTES IN EUROPE 43

TABLE 10 TOP RESEARCH INSTITUTES IN ASIA-PACIFIC 44

TABLE 11 TOP RESEARCH INSTITUTES IN MIDDLE EAST & AFRICA 45

TABLE 12 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 47

TABLE 13 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR KITS AND REAGENTS, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 14 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 15 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 16 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 17 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ELISA, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 18 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ELISPOT, BY REGION, 2020–2027 (USD MILLION) 54

TABLE 19 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR RIA, BY REGION, 2020–2027 (USD MILLION) 55

TABLE 20 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR CLIA, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 21 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR FLUOROIMMUNOASSAY, BY REGION, 2020–2027 (USD MILLION) 57

TABLE 22 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59

TABLE 23 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR INFECTIOUS DISEASES, BY REGION, 2020–2027 (USD MILLION) 60

TABLE 24 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR CANCER RESEARCH, BY REGION, 2020–2027 (USD MILLION) 61

TABLE 25 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ENDOCRINOLOGY, BY REGION, 2020–2027 (USD MILLION) 62

TABLE 26 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2020–2027 (USD MILLION) 63

TABLE 27 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 65

TABLE 28 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION,

2020–2027 (USD MILLION) 66

TABLE 29 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY REGION,

2020–2027 (USD MILLION) 67

TABLE 30 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 67

TABLE 31 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020–2027 (USD MILLION) 70

TABLE 32 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020–2027 (USD MILLION) 71

TABLE 33 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 72

TABLE 34 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 35 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 73

TABLE 36 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 73

TABLE 37 AMERICAS: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 74

TABLE 38 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74

TABLE 39 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 75

TABLE 40 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 41 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76

TABLE 42 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 76

TABLE 43 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 77

TABLE 44 US: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 77

TABLE 45 US: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 46 US: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 78

TABLE 47 US: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 79

TABLE 48 US: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 79

TABLE 49 CANADA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 80

TABLE 50 CANADA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 51 CANADA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81

TABLE 52 CANADA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 81

TABLE 53 CANADA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 82

TABLE 54 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 82

TABLE 55 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 56 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 57 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 84

TABLE 58 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 84

TABLE 59 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020–2027 (USD MILLION) 85

TABLE 60 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 86

TABLE 61 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 62 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87

TABLE 63 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 87

TABLE 64 EUROPE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 88

TABLE 65 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89

TABLE 66 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 89

TABLE 67 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 68 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 90

TABLE 69 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 91

TABLE 70 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 91

TABLE 71 GERMANY: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 92

TABLE 72 GERMANY: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 73 GERMANY: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93

TABLE 74 GERMANY: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 93

TABLE 75 GERMANY: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 94

TABLE 76 FRANCE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 94

TABLE 77 FRANCE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 78 FRANCE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95

TABLE 79 FRANCE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 96

TABLE 80 FRANCE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 96

TABLE 81 UK: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 97

TABLE 82 UK: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 83 UK: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98

TABLE 84 UK: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 98

TABLE 85 UK: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 99

TABLE 86 ITALY: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 99

TABLE 87 ITALY: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 88 ITALY: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100

TABLE 89 ITALY: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 101

TABLE 90 ITALY: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 101

TABLE 91 SPAIN: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 102

TABLE 92 SPAIN: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 93 SPAIN: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103

TABLE 94 SPAIN: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 103

TABLE 95 SPAIN: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 104

TABLE 96 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 104

TABLE 97 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 98 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105

TABLE 99 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 106

TABLE 100 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 106

TABLE 101 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 107

TABLE 102 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 107

TABLE 103 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 108

TABLE 104 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 108

TABLE 105 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES,

BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 106 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110

TABLE 107 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 110

TABLE 108 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 109 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 111

TABLE 110 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 112

TABLE 111 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 112

TABLE 112 NORWAY: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 113

TABLE 113 NORWAY: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 113

TABLE 114 NORWAY: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 114

TABLE 115 NORWAY: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 114

TABLE 116 NORWAY: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 115

TABLE 117 SWEDEN: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 115

TABLE 118 SWEDEN: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 116

TABLE 119 SWEDEN: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 116

TABLE 120 SWEDEN: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 117

TABLE 121 SWEDEN: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 117

TABLE 122 DENMARK: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 118

TABLE 123 DENMARK: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 118

TABLE 124 DENMARK: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119

TABLE 125 DENMARK: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 119

TABLE 126 DENMARK: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 120

TABLE 127 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 120

TABLE 128 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 121

TABLE 129 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121

TABLE 130 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 122

TABLE 131 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES,

BY TYPE, 2020–2027 (USD MILLION) 122

TABLE 132 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 123

TABLE 133 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 123

TABLE 134 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124

TABLE 135 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 124

TABLE 136 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 125

TABLE 137 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 126

TABLE 138 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 127

TABLE 139 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 127

TABLE 140 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128

TABLE 141 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 128

TABLE 142 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 129

TABLE 143 JAPAN: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 129

TABLE 144 JAPAN: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 130

TABLE 145 JAPAN: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130

TABLE 146 JAPAN: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 131

TABLE 147 JAPAN: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 131

TABLE 148 CHINA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 132

TABLE 149 CHINA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 132

TABLE 150 CHINA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 133

TABLE 151 CHINA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 133

TABLE 152 CHINA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 134

TABLE 153 INDIA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134

TABLE 154 INDIA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 135

TABLE 155 INDIA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135

TABLE 156 INDIA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 136

TABLE 157 INDIA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 136

TABLE 158 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 137

TABLE 159 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 137

TABLE 160 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 138

TABLE 161 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 138

TABLE 162 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 139

TABLE 163 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 139

TABLE 164 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 140

TABLE 165 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140

TABLE 166 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 141

TABLE 167 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 141

TABLE 168 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 142

TABLE 169 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 142

TABLE 170 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143

TABLE 171 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 143

TABLE 172 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 144

TABLE 173 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020–2027 (USD MILLION) 145

TABLE 174 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 146

TABLE 175 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 146

TABLE 176 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147

TABLE 177 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 147

TABLE 178 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 148

TABLE 179 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 148

TABLE 180 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 149

TABLE 181 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 149

TABLE 182 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 150

TABLE 183 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 150

TABLE 184 AFRICA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 151

TABLE 185 AFRICA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 151

TABLE 186 AFRICA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152

TABLE 187 AFRICA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 152

TABLE 188 AFRICA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,

2020–2027 (USD MILLION) 153

15 List Of Figures

FIGURE 1 GLOBAL IMMUNOASSAY IN R&D MARKET: MARKET STRUCTURE 21

FIGURE 2 RESEARCH PROCESS OF MRFR 23

FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACHES 26

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE IMMUNOASSAYS IN R&D MARKET 28

FIGURE 5 VALUE CHAIN ANALYSIS: GLOBAL IMMUNOASSAYS IN R&D MARKET 33

FIGURE 6 PORTER’S FIVE FORCE ANALYSIS: GLOBAL IMMUNOASSAYS IN R&D MARKET 34

FIGURE 7 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020 AND 2027 (USD MILLION) 47

FIGURE 8 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020 AND 2027 (USD MILLION) 52

FIGURE 9 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020 AND 2027 (USD MILLION) 59

FIGURE 10 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020 AND 2027 (USD MILLION) 65

FIGURE 11 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 70

FIGURE 12 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020 (%) 71

FIGURE 13 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020 (%) 74

FIGURE 14 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020 (%) 85

FIGURE 15 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020 (%) 88

FIGURE 16 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020 (%) 109

FIGURE 17 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020 (%) 126

FIGURE 18 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020 (%) 145

FIGURE 19 GLOBAL IMMUNOASSAY IN R&D MARKET SHARE ANALYSIS, 2020 (%) 155

Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid